Day One Biopharmaceuticals Stock Market Value

DAWN Stock  USD 13.72  0.38  2.85%   
Day One's market value is the price at which a share of Day One trades on a public exchange. It measures the collective expectations of Day One Biopharmaceuticals investors about its performance. Day One is selling at 13.72 as of the 25th of November 2024; that is 2.85 percent increase since the beginning of the trading day. The stock's open price was 13.34.
With this module, you can estimate the performance of a buy and hold strategy of Day One Biopharmaceuticals and determine expected loss or profit from investing in Day One over a given investment horizon. Check out Day One Correlation, Day One Volatility and Day One Alpha and Beta module to complement your research on Day One.
Symbol

Day One Biopharmaceu Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.144
Return On Assets
(0.25)
Return On Equity
(0.18)
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Day One 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Day One's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Day One.
0.00
12/06/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
11/25/2024
0.00
If you would invest  0.00  in Day One on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding Day One Biopharmaceuticals or generate 0.0% return on investment in Day One over 720 days. Day One is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted thera... More

Day One Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Day One's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Day One Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Day One Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Day One's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Day One's standard deviation. In reality, there are many statistical measures that can use Day One historical prices to predict the future Day One's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
11.2313.7316.23
Details
Intrinsic
Valuation
LowRealHigh
12.3520.1122.61
Details
Naive
Forecast
LowNextHigh
10.2012.6915.19
Details
10 Analysts
Consensus
LowTargetHigh
35.2938.7843.05
Details

Day One Biopharmaceu Backtested Returns

Day One Biopharmaceu secures Sharpe Ratio (or Efficiency) of -0.0038, which denotes the company had a -0.0038% return per unit of risk over the last 3 months. Day One Biopharmaceuticals exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Day One's Coefficient Of Variation of 7013.6, mean deviation of 2.1, and Downside Deviation of 2.83 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.91, which means possible diversification benefits within a given portfolio. Day One returns are very sensitive to returns on the market. As the market goes up or down, Day One is expected to follow. At this point, Day One Biopharmaceu has a negative expected return of -0.0095%. Please make sure to confirm Day One's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Day One Biopharmaceu performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.03  

Very weak reverse predictability

Day One Biopharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Day One time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Day One Biopharmaceu price movement. The serial correlation of -0.03 indicates that only 3.0% of current Day One price fluctuation can be explain by its past prices.
Correlation Coefficient-0.03
Spearman Rank Test0.14
Residual Average0.0
Price Variance1.28

Day One Biopharmaceu lagged returns against current returns

Autocorrelation, which is Day One stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Day One's stock expected returns. We can calculate the autocorrelation of Day One returns to help us make a trade decision. For example, suppose you find that Day One has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Day One regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Day One stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Day One stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Day One stock over time.
   Current vs Lagged Prices   
       Timeline  

Day One Lagged Returns

When evaluating Day One's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Day One stock have on its future price. Day One autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Day One autocorrelation shows the relationship between Day One stock current value and its past values and can show if there is a momentum factor associated with investing in Day One Biopharmaceuticals.
   Regressed Prices   
       Timeline  

Pair Trading with Day One

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Day One position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will appreciate offsetting losses from the drop in the long position's value.

Moving against Day Stock

  0.47MTEM Molecular TemplatesPairCorr
The ability to find closely correlated positions to Day One could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Day One when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Day One - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Day One Biopharmaceuticals to buy it.
The correlation of Day One is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Day One moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Day One Biopharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Day One can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Day One Correlation, Day One Volatility and Day One Alpha and Beta module to complement your research on Day One.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Day One technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Day One trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...